Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study

BACKGROUND: OnabotulinumtoxinA is effective in preventing chronic migraine (CM); however, the benefit of onabotulinumtoxinA in patients with CM with daily headache is unknown because these patients are typically excluded from clinical trials. This subanalysis of the COMPEL Study assessed the efficac...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Headache Pain
Huvudupphovsmän: Young, William B., Ivan Lopez, J., Rothrock, John F., Orejudos, Amelia, Manack Adams, Aubrey, Lipton, Richard B., Blumenfeld, Andrew M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Milan 2019
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734507/
https://ncbi.nlm.nih.gov/pubmed/30709333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0953-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk